Cidara

CDTX NASDAQ
1.610
+0.010
+0.63%
交易中 15:28 06/18 EDT
开盘
1.640
昨收
1.600
最高
1.660
最低
1.560
成交量
9.69万
成交均量(3M)
14.54万
52周最高
5.75
52周最低
1.410
换手率
0.36%
市值
4,289.34万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Cidara CDTX股票价格,Cidara股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Cidara Therapeutics Inc., is a clinical-stage biotechnology company focused on developing new anti-infectives. The Company’s lead product candidate is rezafungin acetate, which is a molecule in the echinocandin class of antifungals for the treatment and prevention of serious invasive fungal infections, including candidemia and invasive candidiasis, fungal infections associated with high mortality rates. The Company is also leveraging its novel Cloudbreak platform to develop antibody-drug conjugates for the treatment of serious viral and Gram-negative bacterial infections. Cloudbreak is the immunotherapy discovery platform designed specifically to create compounds that directly kill pathogens and also direct a patient’s immune cells to attack and eliminate bacterial, fungal or viral pathogens.
展开 >

最近浏览

名称
价格
涨跌幅